NCT03011333 - Phase 2B Upper Extremity Nerve Block Study | Biotech Hunter

Enrollment

243

Participants

Timeline

Start Date

January 14, 2017

Primary Completion Date

February 1, 2018

Study Completion Date

March 19, 2018

Conditions

Postoperative Pain

Interventions

DRUG

HTX-011

HTX-011 (bupivacaine/meloxicam) via nerve block or instillation.

DRUG

Bupivacaine HCl without epinephrine

Bupivacaine HCl without epinephrine, 50 mg via nerve block.

DRUG

Saline Placebo

Saline placebo via nerve block.

Trial Locations (2)

Houston

Pasadena